HKSE · 0455.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 27, 2026, 07:46 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Tianda Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tianda Pharmaceuticals Limited’s forward annual dividend is HK$0.00 per share, paid annual. The forward yield is 2.92% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tianda Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 1992 and headquartered in Central, Hong Kong, Tianda Pharmaceuticals Limited operates as an investment holding company and a subsidiary of Tianda Group Limited. The firm, which changed its name from Tianda Holdings Limited in September 2012, focuses on the research, development, manufacturing, and distribution of a wide array of pharmaceutical, biotechnology, and healthcare products. Its commercial reach extends across Mainland China, Hong Kong, and Australia. The company's diverse portfolio includes traditional Chinese medicines, chemical drugs, biological products, and medical appliances. These offerings target numerous therapeutic areas, such as cardio-cerebrovascular health, pediatric care, anti-flu and respiratory conditions, anti-infection, detoxification, and urological disorders. Health supplements are specifically marketed under the "Herb Valley" and "Tuokang" brand names. Furthermore, Tianda Pharmaceuticals is involved in the wholesale and retail of Chinese herbal medicines, traditional Chinese medicine (TCM) decoction pieces, and other Chinese medicinal products, provides Chinese medical services, and trades agricultural by-products.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.57-HK$0.01 (-0.32%)
Mediwelcome Healthcare Management & Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 30.84% below the high.
HK$0.26HK$0.00 (0.0%)
China Health Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
HK$0.25+HK$0.00 (+0.82%)
Tycoon Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.36% below the high.
HK$0.37-HK$0.02 (-3.9%)
Kingworld Medicines Group Limited’s quoted price sits in the lower half of its reported 52-week range, 52.56% below the high.
HK$0.10-HK$0.01 (-6.36%)
Shenzhen Neptunus Interlong Bio-technique Company Limited’s quoted price sits in the lower half of its reported 52-week range, 42.46% below the high.
HK$0.03HK$0.00 (0.0%)
Tai United Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
HK$0.06-HK$0.00 (-1.56%)
Yestar Healthcare Holdings Company Limited’s quoted price sits in the lower half of its reported 52-week range, 53.68% below the high.
HK$0.04-HK$0.01 (-13.73%)
Extrawell Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 61.74% below the high.
